1Anderson R, Lui F. Increased heparinization and its effection dialyzer reuse. Dial Transpl, 1995；24(8):464～468
2Schrader J, Stible W, Armstrong VW et al. Comparison of low molecular weight heparin to standard heparin in hemodialysis/ hemofiltration. Kidney Int, 1988；33(4):890～895
3Teitel JM, Rosenberg RD. Protection of factor Xa from neutrlization by the heparin-antithrombin complex. J Clin Invest, 1983；71(10):1383～1386
4Shaldon S, Koch KM. Survival and adequacy in long-term hemodialysis(editorial). Nephron, 1998,59(3):353～358
5Wei SS, Ellis PW,Magnusson MO et al. Effect of heparin modeling on delivered hemodialysis therapy. Am J Kid Dis, 1994；23(3):389～394
6Holmer E, Mattson C, Nilsson S. Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragment in rabbits. Thromb Res, 1982；25(4):475～479
8Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparin. Drugs, 1994；40(7):498～504
9Gran E, Siguenza F, Maduall F et al. Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis. Nephron, 1996,62(1):13～18
